#Venture Capital
Total 25 articles
Explore the 9 standout cybersecurity startups from TechCrunch Disrupt 2025's Startup Battlefield. From AI defense to deepfake detection, see the future of tech.
China has launched a national venture capital fund aimed at early-stage tech startups, potentially steering trillions of yuan into strategic industries across major regional hubs.
European startups saw €43.7 billion in funding in 2025, but the market's recovery lags behind the U.S. Is a turnaround imminent, fueled by AI investment and renewed interest from American VCs?
HashKey Capital, a leading Asian digital asset manager, has secured $250 million in the first close of its new $500 million crypto fund focused on real-world use cases.
Enterprise software giant ServiceNow is acquiring cybersecurity startup Armis for $7.75 billion in cash, a move that shelves Armis's IPO plans and signals ServiceNow's aggressive platform strategy.
AI avatar startup Lemon Slice has raised $10.5 million in seed funding to create realistic, interactive video avatars from a single image, aiming to solve the 'uncanny valley' problem with its custom diffusion model.
India's quick commerce sector is expanding beyond groceries to fashion, electronics, and services. But as competition soars, market consolidation is on the horizon.
SoftBank is reportedly rushing to complete a massive $22.5 billion investment in OpenAI by the end of 2025, a landmark deal that could reshape the AI landscape. Here's what it means for the industry.
Jon Medved, founder of VC firm OurCrowd and a pillar of Israel's tech scene, retires after an ALS diagnosis. Now, he's turning to the AI avatars and health tech he once funded to fight the disease.
Sequoia partner Shaun Maguire's false accusation is more than a PR crisis. It's a test for new leadership and exposes a strategic schism in venture capital.
Resolve AI's $1B valuation on just $4M ARR reveals a new VC playbook for AI. We analyze the 'synthetic unicorn' deal and the future of autonomous SREs.
Startups in regulated industries face more than just the FDA. A new analysis of the 'Legislative Quilt' vs. the 'Regulatory Moat' for founders and VCs.